Roger Adsett
Directeur des opérations chez INSMED INCORPORATED
Fortune : 10 M $ au 30/06/2024
Profil
Roger Adsett's current job is Chief Operating Officer at Insmed, Inc. He previously worked as Director-Marketing & Brand at AstraZeneca PLC from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. In addition, he served as Independent Director at Landos Biopharma, Inc. from 2022 to 2024.
Prior to his current role, he was the SVP, Head-Gastrointestinal & Internal Medicine at Shire Plc from 2015 to 2016.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED
0,09% | 17/05/2024 | 149 275 ( 0,09% ) | 10 M $ | 30/06/2024 |
Postes actifs de Roger Adsett
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Directeur des opérations | 14/11/2019 |
Anciens postes connus de Roger Adsett
| Sociétés | Poste | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur/Membre du Conseil | 23/05/2024 |
| SHIRE | Corporate Officer/Principal | 01/09/2016 |
| ASTRAZENECA PLC | Sales & Marketing | 01/10/2005 |
| Nexium, Inc. | Sales & Marketing | - |
| AstraZeneca R & D Lund | Sales & Marketing | - |
Formation de Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
